Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Lemborexant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,494Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eisai's Robust Neurology Portfolio At AAN 2024
    Eisai's Robust Neurology Portfolio At AAN 2024

    12 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-to-present-data-on-robust-neurology-portfolio-at-the-76th-american-academy-of-neurology-aan-annual-meeting-302114979.html

    PR NEWSWIRE
    12 Apr 2024
    Share Share
    Eisai to Present Latest DAYVIGO CIV Data at 35th Annual SLEEP 2021 Meeting
    Eisai to Present Latest DAYVIGO CIV Data at 35th Annual SLEEP 2021 Meeting

    09 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-to-present-latest-dayvigo-lemborexant-civ-data-at-35th-annual-virtual-sleep-2021-meeting-301308305.html

    PRNEWSWIRE
    09 Jun 2021
    Share Share
    Eisai’s anti-insomnia drug, Dayvigo gets approval in Hong Kong
    Eisai’s anti-insomnia drug, Dayvigo gets approval in Hong Kong

    02 Mar 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=135866&sid=2

    PHARMABIZ
    02 Mar 2021
    Share Share
    Health Canada Authorizes DAYVIGO™ (lemborexant)
    Health Canada Authorizes DAYVIGO™ (lemborexant)

    04 Feb 2021

    // GLOBENEWSWIRE

    https://www.newswire.ca/fr/news-releases/sante-canada-autorise-dayvigo-lemborexant--876441695.html

    GLOBENEWSWIRE
    04 Feb 2021
    Share Share
    Eisai Presents New Analyses from Phase 3 Studies of DAYVIGO™ (lemborexant)
    Eisai Presents New Analyses from Phase 3 Studies of DAYVIGO™ (lemborexant)

    28 Aug 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-presents-new-analyses-from-phase-3-studies-of-dayvigo-lemborexant-civ-for-the-treatment-of-insomnia-in-adult-patients-at-virtual-sleep-2020-301120401.html

    PRNEWSWIRE
    28 Aug 2020
    Share Share
    Eisai to Present Latest Insomnia Research, Including Data on New DAYVIGO™
    Eisai to Present Latest Insomnia Research, Including Data on New DAYVIGO™

    24 Aug 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-to-present-latest-insomnia-research-including-data-on-new-treatment-dayvigo-lemborexant-civ-at-the-sleep-2020-virtual-conference-301116731.html

    PRNEWSWIRE
    24 Aug 2020
    Share Share